Cargando…
DF2726A, a new IL-8 signalling inhibitor, is able to counteract chemotherapy-induced neuropathic pain
Chemotherapy-induced peripheral neuropathy (CIPN) is a common dose-limiting side effect of several anti-neoplastics and a main cause of sensory disturbances in cancer survivors, negatively impacting patients’ quality of life. Peripheral nerve degeneration or small fibre neuropathy is generally accep...
Autores principales: | Brandolini, Laura, Castelli, Vanessa, Aramini, Andrea, Giorgio, Cristina, Bianchini, Gianluca, Russo, Roberto, De Caro, Carmen, d’Angelo, Michele, Catanesi, Mariano, Benedetti, Elisabetta, Giordano, Antonio, Cimini, Annamaria, Allegretti, Marcello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692352/ https://www.ncbi.nlm.nih.gov/pubmed/31409858 http://dx.doi.org/10.1038/s41598-019-48231-z |
Ejemplares similares
-
CXCR1/2 pathways in paclitaxel-induced neuropathic pain
por: Laura, Brandolini, et al.
Publicado: (2017) -
Inflammation-Independent Antinociceptive Effects of DF2755A, a CXCR1/2 Selective Inhibitor: A New Potential Therapeutic Treatment for Peripheral Neuropathy Associated to Non-Ulcerative Interstitial Cystitis/Bladder Pain Syndrome
por: Brandolini, Laura, et al.
Publicado: (2022) -
Chemokine Signaling in Chemotherapy-Induced Neuropathic Pain
por: Brandolini, Laura, et al.
Publicado: (2019) -
Probiotic DSF counteracts chemotherapy induced neuropathic pain
por: Castelli, Vanessa, et al.
Publicado: (2018) -
S-Carboxymethyl Cysteine Protects against Oxidative Stress and Mitochondrial Impairment in a Parkinson’s Disease In Vitro Model
por: Catanesi, Mariano, et al.
Publicado: (2021)